Stock Financial Ratios and Split History

MIRN / Mirna Therapeutics, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)34.62
Enterprise Value ($M)19.37
Book Value ($M)60.35
Book Value / Share2.89
Price / Book0.28
NCAV ($M)57.57
NCAV / Share2.95
Price / NCAV0.28
Income Statement (mra) ($M)
Net Income-26.27
Balance Sheet (mrq) ($M)
Cash & Equivalents79.17
Cash / Share3.80
Quick Ratio22.23
Current Ratio22.23
Share Statistics
Common Stock Shares Outstanding20,841,393
Common Shares Outstanding20,856,693
Preferred Stock Shares Outstanding0
Scoring Models
Piotroski F-Score1.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.44
Return on Assets (ROA)-0.41
Return on Equity (ROE)-0.44
Identifiers and Descriptors
Central Index Key (CIK)1527599
Industry Groups
SIC 2834 - Pharmaceutical Preparations

Split History

Stock splits are used by Mirna Therapeutics, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Peers - Pharmaceutical Preparations (2834)

Related News Stories

Miragen Therapeutics May Provide Long Term Alpha Within The RNA Space

2018-02-01 seekingalpha
At Stockmatusow, we look for developmental biotech companies we believe provide a legitimate chance at long-term large alpha potential. These factors include, but are not limited to; (60-2)

Synlogic: Precision-Programmed Probiotics To Treat Human Disease

2018-01-29 seekingalpha
Synlogic develops medicines using probiotic engineering to treat inborn errors of metabolism, immunomodulation, and metabolic diseases. (95-2)

CUSIP: 87166L100